HANNAH SMITH: Open Payments
NPI 1962155408 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,076 in 184 payments from 22 companies in 2025. Trend: 2023 $2,536 · 2024 $3,769 · 2025 $3,076
Food & beverage: $2,996Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $578 |
| Novartis Pharmaceuticals Corporation | 26 | $429 |
| UCB, Inc. | 19 | $385 |
| Janssen Biotech, Inc. | 29 | $354 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $274 |
| Incyte Corporation | 14 | $218 |
| GENZYME CORPORATION | 10 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $109 |
| Lilly USA, LLC | 4 | $93 |
| LEO Pharma Inc. | 3 | $58 |
Products named: SKYRIZI, Bimzelx, TREMFYA, COSENTYX, DUPIXENT, OPZELURA, RINVOQ, Rhapsido.
Industry payments across AL — which companies pay providers there.
